Ocular Therapeutix (OCUL) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.55% |
| Dec 31, 2025 | -113.78% |
| Sep 30, 2025 | 11.85% |
| Jun 30, 2025 | -11.85% |
| Mar 31, 2025 | 10.82% |
| Dec 31, 2024 | 8.22% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | 4.83% |
| Mar 31, 2024 | -146.50% |
| Dec 31, 2023 | -77.26% |
| Sep 30, 2023 | -65.98% |
| Jun 30, 2023 | 15.72% |
| Mar 31, 2023 | 22.75% |
| Dec 31, 2022 | 15.42% |
| Sep 30, 2022 | 10.10% |
| Jun 30, 2022 | 7.48% |
| Mar 31, 2022 | 11.42% |
| Dec 31, 2021 | 8.43% |
| Sep 30, 2021 | 6.56% |
| Jun 30, 2021 | 8.37% |
| Mar 31, 2021 | 8.19% |
| Dec 31, 2020 | -222.83% |
| Sep 30, 2020 | 16.20% |
| Jun 30, 2020 | -75.06% |
| Mar 31, 2020 | 11.55% |
| Dec 31, 2019 | 16.78% |
| Sep 30, 2019 | -5.91% |
| Jun 30, 2019 | 19.00% |
| Mar 31, 2019 | -41.04% |
| Dec 31, 2018 | 4.92% |
| Sep 30, 2018 | -0.05% |
| Jun 30, 2018 | 9.66% |
| Mar 31, 2018 | -51.45% |
| Dec 31, 2017 | 18.82% |
| Sep 30, 2017 | 22.53% |
| Jun 30, 2017 | 17.83% |
| Mar 31, 2017 | -17.95% |
| Dec 31, 2016 | 10.04% |
| Sep 30, 2016 | 9.70% |
| Jun 30, 2016 | 12.12% |
| Mar 31, 2016 | 9.14% |
| Dec 31, 2015 | 7.55% |
| Sep 30, 2015 | 8.15% |
| Jun 30, 2015 | -83.50% |
| Mar 31, 2015 | 9.90% |
| Dec 31, 2014 | 7.50% |
| Sep 30, 2014 | -305.60% |
| Jun 30, 2014 | -56.42% |
| Mar 31, 2014 | 27.16% |
| Dec 31, 2013 | 19.02% |
| Sep 30, 2013 | 13.64% |